The EPA Management Standards for Hazardous Waste Pharmaceuticals Rule was published in the Federal Register on September 25, 2015. EPA received a number of requests to extend the comment period and in response provided a 30-day extension. A notice announcing this extension was published in the Federal Register on November 5, 2015.
The rule proposes a tailored, sector-specific set of regulations for the management of hazardous waste pharmaceuticals by healthcare facilities (including pharmacies) and reverse distributors. It is intended to provide standards to ensure the management of hazardous waste pharmaceuticals is safe and workable within the healthcare setting. In addition, the proposed pharmaceutical rule is intended to reduce the amount of pharmaceuticals entering surface water.
States, such as Washington, has proposed their own interim policies regarding shipping of waste drugs which would otherwise be regulated as hazardous waste or dangerous waste.